Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free SAIC Stock Alerts

Science Applications International (SAIC) Financials

Science Applications International logo
$111.71 -1.49 (-1.32%)
As of 11:40 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Science Applications International

Annual Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 117 143 179 137 226 209 277 300 477 362 358
Consolidated Net Income / (Loss)		 117 143 179 137 229 211 279 303 477 362 358
Net Income / (Loss) Continuing Operations		 117 143 179 137 229 211 279 303 477 362 358
Total Pre-Tax Income 		183 212 214 170 286 271 358 375 620 428 387
Total Operating Income		 227 263 256 220 370 390 462 501 741 563 521
Total Gross Profit		 411 439 411 464 706 792 859 888 872 892 872
Total Revenue		 4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479 7,262
Operating Revenue		 4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479 7,262
Total Cost of Revenue		 3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587 6,390
Operating Cost of Revenue		 3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587 6,390
Total Operating Expenses		 184 176 155 244 336 402 397 387 131 329 351
Selling, General & Admin Expense		 184 166 155 158 288 352 344 374 373 339 350
Other Operating Expenses / (Income)		 - - - 0.00 0.00 -4.00 -1.00 13 -2.00 -10 1.00
Other Special Charges / (Income)		 - - - - - - -2.00 0.00 -240 0.00 0.00
Total Other Income / (Expense), net		 -44 -51 -42 -50 -84 -119 -104 -126 -121 -135 -134
Interest Expense		 44 52 44 53 90 122 105 118 120 126 128
Other Income / (Expense), net		 0.00 1.00 2.00 3.00 6.00 3.00 1.00 -8.00 -1.00 -9.00 -6.00
Income Tax Expense		 66 69 35 33 57 60 79 72 143 66 29
Basic Earnings per Share		 $2.55 $3.21 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23 $7.73
Weighted Average Basic Shares Outstanding		 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Diluted Earnings per Share		 $2.47 $3.12 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17 $7.70
Weighted Average Diluted Shares Outstanding		 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Weighted Average Basic & Diluted Shares Outstanding		 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Cash Dividends to Common per Share		 $1.21 $1.24 $1.24 $1.24 $1.48 $1.48 $1.48 $1.48 $1.48 $1.48 $1.48

Quarterly Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026
Net Income / (Loss) Attributable to Common Shareholders		 93 39 77 81 106 98 68 127 78 85 115
Consolidated Net Income / (Loss)		 93 39 77 81 106 98 68 127 78 85 115
Net Income / (Loss) Continuing Operations		 93 39 77 81 106 98 68 127 78 85 115
Total Pre-Tax Income 		114 48 95 100 126 107 86 108 94 99 145
Total Operating Income		 143 79 131 134 160 138 121 139 128 133 179
Total Gross Profit		 229 192 213 210 237 232 209 215 227 221 249
Total Revenue		 1,895 1,737 1,847 1,818 1,976 1,838 1,877 1,769 1,866 1,750 1,906
Operating Revenue		 1,895 1,737 1,847 1,818 1,976 1,838 1,877 1,769 1,866 1,750 1,906
Total Cost of Revenue		 1,666 1,545 1,634 1,608 1,739 1,606 1,668 1,554 1,639 1,529 1,657
Operating Cost of Revenue		 1,666 1,545 1,634 1,608 1,739 1,606 1,668 1,554 1,639 1,529 1,657
Total Operating Expenses		 86 113 82 76 77 94 88 76 99 88 70
Selling, General & Admin Expense		 87 114 85 77 83 94 89 75 101 85 83
Other Operating Expenses / (Income)		 -1.00 -1.00 -3.00 -1.00 -6.00 - -1.00 1.00 -2.00 3.00 -13
Total Other Income / (Expense), net		 -29 -31 -36 -34 -34 -31 -35 -31 -34 -34 -34
Interest Expense		 27 32 34 31 32 29 30 31 33 34 33
Other Income / (Expense), net		 -2.00 1.00 -2.00 -3.00 -2.00 -2.00 -5.00 0.00 -1.00 - -1.00
Income Tax Expense		 21 9.00 18 19 20 9.00 18 -19 16 14 30
Basic Earnings per Share		 $1.79 $0.79 $1.49 $1.59 $2.15 $2.00 $1.43 $2.72 $1.70 $1.88 $2.63
Weighted Average Basic Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Diluted Earnings per Share		 $1.76 $0.77 $1.48 $1.58 $2.13 $1.98 $1.42 $2.71 $1.69 $1.88 $2.61
Weighted Average Diluted Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Weighted Average Basic & Diluted Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Cash Dividends to Common per Share		 $0.37 - $0.37 $0.37 $0.37 - $0.37 $0.37 $0.37 - $0.37

Annual Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Net Change in Cash & Equivalents		 -92 9.00 -66 94 -44 -12 -75 3.00 -15 -39 126
Net Cash From Operating Activities		 226 273 217 184 458 755 518 532 396 494 609
Net Cash From Continuing Operating Activities		 226 273 217 184 458 755 518 532 396 494 609
Net Income / (Loss) Continuing Operations		 117 143 179 137 229 211 279 303 477 362 358
Consolidated Net Income / (Loss)		 117 143 179 137 229 211 279 303 477 362 358
Depreciation Expense		 62 53 46 47 131 179 165 157 142 140 149
Non-Cash Adjustments To Reconcile Net Income		 24 16 27 85 42 54 62 47 -185 46 65
Changes in Operating Assets and Liabilities, net		 23 61 -35 -87 49 305 38 25 -38 -54 37
Net Cash From Investing Activities		 -784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35 -248
Net Cash From Continuing Investing Activities		 -784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35 -248
Purchase of Property, Plant & Equipment		 -20 -15 -22 -28 -21 -46 -36 -25 -27 -36 -32
Acquisitions		 -764 0.00 0.00 -1,001 0.00 -1,202 -255 0.00 -8.00 0.00 -203
Purchase of Investments		 - - 0.00 0.00 -24 -6.00 -9.00 -7.00 -18 -21 -20
Divestitures		 - - - 0.00 0.00 17 8.00 0.00 356 10 0.00
Sale and/or Maturity of Investments		 - - 0.00 0.00 3.00 9.00 6.00 4.00 6.00 12 7.00
Other Investing Activities, net		 - -2.00 0.00 1.00 -5.00 -3.00 -6.00 -8.00 5.00 0.00 0.00
Net Cash From Financing Activities		 466 -247 -261 938 -455 464 -301 -493 -725 -498 -235
Net Cash From Continuing Financing Activities		 466 -247 -261 938 -455 464 -301 -493 -725 -498 -235
Repayment of Debt		 -89 -238 -50 -805 -274 -426 -119 -999 -441 -1,384 -2,487
Repurchase of Common Equity		 -69 -180 -186 -71 -197 -34 -226 -267 -382 -558 -445
Payment of Dividends		 -55 -54 -54 -52 -94 -89 -88 -83 -79 -75 -70
Issuance of Debt		 670 209 25 1,859 100 1,000 116 840 160 1,499 2,745
Issuance of Common Equity		 4.00 5.00 6.00 7.00 10 13 16 16 17 20 22
Cash Interest Paid		 36 48 41 44 86 96 98 111 125 121 101

Quarterly Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026
Net Change in Cash & Equivalents		 -41 -217 -45 -2.00 -2.00 10 -9.00 1.00 -3.00 137 -73
Net Cash From Operating Activities		 101 63 98 138 143 115 100 122 129 258 127
Net Cash From Continuing Operating Activities		 101 63 98 136 143 115 100 122 129 258 127
Net Income / (Loss) Continuing Operations		 93 39 77 81 106 98 68 127 78 85 115
Consolidated Net Income / (Loss)		 93 39 77 81 106 98 68 127 78 85 115
Depreciation Expense		 34 36 35 34 35 36 36 35 38 40 40
Non-Cash Adjustments To Reconcile Net Income		 14 24 12 8.00 7.00 17 16 10 22 18 -1.00
Changes in Operating Assets and Liabilities, net		 -40 -36 -26 13 -5.00 -36 -20 -50 -9.00 115 -27
Net Cash From Investing Activities		 -10 -10 -7.00 -9.00 1.00 -20 -15 -7.00 -215 -11 1.00
Net Cash From Continuing Investing Activities		 -10 -10 -7.00 -9.00 1.00 -20 -15 -7.00 -215 -11 1.00
Purchase of Property, Plant & Equipment		 -4.00 -11 -6.00 -6.00 -9.00 -15 -8.00 -7.00 -9.00 -8.00 -9.00
Purchase of Investments		 -1.00 -2.00 -4.00 -4.00 -3.00 -3.00 -4.00 - -1.00 -15 -4.00
Sale and/or Maturity of Investments		 1.00 1.00 4.00 2.00 4.00 2.00 3.00 1.00 1.00 2.00 20
Other Investing Activities, net		 -7.00 5.00 -1.00 -1.00 -1.00 -4.00 -6.00 -1.00 -3.00 10 -6.00
Net Cash From Financing Activities		 -132 -270 -136 -131 -146 -85 -94 -114 83 -110 -201
Net Cash From Continuing Financing Activities		 -132 -270 -136 -131 -146 -85 -94 -114 83 -110 -201
Repayment of Debt		 -15 -166 -310 -296 -450 -328 -689 -550 -1,247 -1.00 -1.00
Repurchase of Common Equity		 -103 -89 -103 -201 -121 -133 -142 -110 -95 -98 -188
Payment of Dividends		 -19 -19 -20 -19 -18 -18 -19 -17 -17 -17 -17
Issuance of Debt		 - - 293 380 441 385 750 557 1,438 - 0.00
Issuance of Common Equity		 5.00 4.00 4.00 5.00 5.00 6.00 6.00 6.00 4.00 6.00 5.00

Annual Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Total Assets		 2,122 2,042 784 4,563 4,711 5,723 5,746 5,543 5,314 5,246 5,354
Total Current Assets		 952 901 753 1,433 1,430 1,289 1,263 1,197 1,131 1,154 1,179
Cash & Equivalents		 195 210 - 237 188 171 106 109 94 56 182
Accounts Receivable		 635 539 673 1,050 1,099 962 1,015 936 914 1,000 853
Prepaid Expenses		 21 27 - 47 40 56 57 58 93 78 122
Other Current Assets		 33 54 14 25 19 22 21 23 30 20 22
Plant, Property, & Equipment, net		 71 60 0.00 103 91 108 100 92 91 104 110
Total Noncurrent Assets		 1,099 1,081 31 3,027 3,190 4,326 4,383 4,254 4,092 3,988 4,065
Goodwill		 860 863 - 2,120 2,139 2,787 2,913 2,911 2,851 2,851 2,944
Intangible Assets		 224 200 - 803 711 1,138 1,132 1,009 894 779 761
Other Noncurrent Operating Assets		 15 18 31 104 340 401 338 320 347 358 360
Total Liabilities & Shareholders' Equity		 2,122 2,042 491 4,563 4,711 5,723 5,746 5,543 5,314 5,246 5,354
Total Liabilities		 1,742 1,693 165 3,064 3,284 4,171 4,117 3,839 3,529 3,669 3,854
Total Current Liabilities		 688 623 94 897 1,128 1,275 1,352 1,126 1,158 1,396 982
Short-Term Debt		 57 25 - 24 70 68 148 31 77 313 19
Accounts Payable		 351 329 - 455 527 517 612 624 567 631 500
Accrued Expenses		 280 269 94 297 405 494 365 266 265 233 147
Current Employee Benefit Liabilities		 - - - 121 126 196 227 205 249 219 316
Total Noncurrent Liabilities		 1,054 1,070 71 2,167 2,156 2,896 2,765 2,713 2,371 2,273 2,872
Long-Term Debt		 1,013 1,022 - 2,065 1,851 2,447 2,370 2,343 2,022 1,907 2,468
Noncurrent Deferred & Payable Income Tax Liabilities		 8.00 10 24 - - 2.00 43 0.00 28 24 104
Other Noncurrent Operating Liabilities		 33 38 47 102 305 447 352 370 321 342 300
Commitments & Contingencies		 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 380 349 326 1,499 1,427 1,552 1,629 1,704 1,785 1,577 1,500
Total Preferred & Common Equity		 380 349 326 1,485 1,417 1,542 1,619 1,694 1,785 1,577 1,500
Total Common Equity		 380 349 326 1,485 1,417 1,542 1,619 1,694 1,785 1,577 1,500
Common Stock		 215 91 - 1,132 983 1,004 838 637 337 0.00 0.00
Retained Earnings		 174 260 326 367 506 627 818 1,035 1,432 1,565 1,492
Accumulated Other Comprehensive Income / (Loss)		 -9.00 -2.00 - -14 -72 -89 -37 22 16 12 8.00

Quarterly Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 10/28/2022 5/5/2023 8/4/2023 11/3/2023 5/3/2024 8/2/2024 11/1/2024 5/2/2025 8/1/2025 10/31/2025 5/1/2026
Total Assets		 5,628 5,957 5,672 5,658 5,250 5,250 5,275 5,211 5,201 5,423 5,338
Total Current Assets		 1,247 1,675 1,384 1,388 1,091 1,103 1,160 1,148 1,204 1,257 1,199
Cash & Equivalents		 53 422 352 311 49 48 46 47 48 45 109
Accounts Receivable		 1,059 995 958 1,010 934 946 1,022 1,009 951 1,045 962
Prepaid Expenses		 135 77 74 67 108 109 92 92 175 145 102
Other Current Assets		 - - - - - - - - 30 22 26
Plant, Property, & Equipment, net		 95 91 90 89 93 95 99 102 104 108 111
Total Noncurrent Assets		 4,286 4,191 4,198 4,181 4,066 4,052 4,016 3,961 3,893 4,058 4,028
Goodwill		 2,911 2,851 2,851 2,851 2,851 2,851 2,851 2,851 2,851 2,960 2,944
Intangible Assets		 1,040 980 951 923 865 836 807 750 721 779 729
Other Noncurrent Operating Assets		 335 360 396 407 350 365 358 360 321 319 355
Total Liabilities & Shareholders' Equity		 5,628 5,957 5,672 5,658 5,250 5,250 5,275 5,211 5,201 5,423 5,338
Total Liabilities		 3,932 4,265 3,829 3,830 3,491 3,625 3,663 3,706 3,684 3,911 3,915
Total Current Liabilities		 1,230 1,553 1,212 1,226 1,154 1,292 1,337 1,474 1,447 1,050 1,037
Short-Term Debt		 15 46 62 69 90 197 220 405 448 12 26
Accounts Payable		 819 809 820 840 648 639 714 668 557 627 634
Accrued Expenses		 - - - - 129 118 92 113 106 103 99
Current Employee Benefit Liabilities		 396 277 330 317 287 338 311 288 336 308 278
Total Noncurrent Liabilities		 2,702 2,712 2,617 2,604 2,337 2,333 2,326 2,232 2,237 2,861 2,878
Long-Term Debt		 2,358 2,329 2,215 2,194 1,993 1,970 1,939 1,876 1,844 2,475 2,460
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 - - - 29 19 12 22 132 124 125
Other Noncurrent Operating Liabilities		 344 383 402 410 315 344 375 334 261 262 293
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,696 1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423
Total Preferred & Common Equity		 1,686 1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423
Total Common Equity		 1,686 1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423
Common Stock		 679 563 480 395 251 63 0.00 0.00 0.00 0.00 0.00
Retained Earnings		 981 1,113 1,340 1,413 1,489 1,551 1,602 1,494 1,508 1,504 1,416
Accumulated Other Comprehensive Income / (Loss)		 26 16 23 20 19 11 10 11 9.00 8.00 7.00

Annual Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
DEI Shares Outstanding		 - - - - - - - - - - 45,127,414.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 45,127,414.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 7.93
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 145 177 214 177 296 304 360 405 570 476 482
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 9.93% 14.68% 12.54% 12.09%
Earnings before Interest and Taxes (EBIT)		 227 264 258 223 376 393 463 493 740 554 515
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 289 317 304 272 514 578 602 650 882 694 664
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -580 246 193 -1,967 487 -432 215 477 749 525 418
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,255 1,186 1,207 3,351 3,160 3,896 4,041 3,969 3,790 3,741 3,805
Increase / (Decrease) in Invested Capital		 725 -69 21 2,144 -191 736 145 -72 -179 -49 64
Book Value per Share		 $8.36 $7.95 $7.65 $34.90 $24.55 $26.48 $28.43 $31.01 $34.29 $32.26 $33.24
Tangible Book Value per Share		 ($15.48) ($16.27) ($16.72) ($33.80) ($24.83) ($40.93) ($42.61) ($40.75) ($37.65) ($42.00) ($48.86)
Total Capital		 1,450 1,396 1,351 3,588 3,348 4,067 4,147 4,078 3,884 3,797 3,987
Total Debt		 1,070 1,047 1,024 2,089 1,921 2,515 2,518 2,374 2,099 2,220 2,487
Total Long-Term Debt		 1,013 1,022 983 2,065 1,851 2,447 2,370 2,343 2,022 1,907 2,468
Net Debt		 875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164 2,305
Capital Expenditures (CapEx)		 20 15 22 28 21 46 36 25 27 36 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 126 93 152 323 184 -89 -47 -7.00 -44 15 34
Debt-free Net Working Capital (DFNWC)		 321 303 296 560 372 82 59 102 50 71 216
Net Working Capital (NWC)		 264 278 255 536 302 14 -89 71 -27 -242 197
Net Nonoperating Expense (NNE)		 28 34 35 40 67 93 81 102 93 114 124
Net Nonoperating Obligations (NNO)		 875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164 2,305
Total Depreciation and Amortization (D&A)		 62 53 46 49 138 185 139 157 142 140 149
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.55 $3.33 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23 $7.73
Adjusted Weighted Average Basic Shares Outstanding		 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Adjusted Diluted Earnings per Share		 $2.47 $3.22 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17 $7.70
Adjusted Weighted Average Diluted Shares Outstanding		 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $4.13 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Normalized Net Operating Profit after Tax (NOPAT)		 145 184 214 247 335 346 402 405 385 476 482
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026
DEI Shares Outstanding		 - - - - - - - - - 45,127,414.00 43,419,313.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 45,127,414.00 43,419,313.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 1.88 2.65
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.73% -11.74% -8.93% 1.91% 4.27% 5.81% 1.62% -2.70% -5.57% - 1.55%
EBITDA Growth		 7.36% -25.16% -14.14% -58.75% 10.29% 48.28% -7.32% 5.45% -14.51% - 43.42%
EBIT Growth		 8.46% -31.03% -16.77% -64.01% 12.06% 70.00% -10.08% 6.11% -19.62% - 53.45%
NOPAT Growth		 9.64% -38.35% -15.12% -59.33% 15.38% 96.91% -9.89% 50.59% -21.09% - 48.38%
Net Income Growth		 16.25% -48.00% -21.43% -67.21% 13.98% 151.28% -11.69% 56.79% -26.42% - 69.12%
EPS Growth		 21.38% -42.54% -17.32% -65.35% 21.02% 157.14% -4.05% 71.52% -20.66% - 83.80%
Operating Cash Flow Growth		 -21.09% -56.55% 19.51% -8.00% 41.58% 82.54% 2.04% -11.59% -9.79% - 27.00%
Free Cash Flow Firm Growth		 152.98% 38.08% -124.12% -74.26% -46.24% -27.88% 195.44% 10.50% -164.76% - -45.91%
Invested Capital Growth		 -5.88% -4.51% 7.45% -0.64% -1.46% -1.29% -1.42% 0.45% 6.15% - 1.63%
Revenue Q/Q Growth		 6.22% -8.34% 6.33% -1.57% 8.69% -6.98% 2.12% -5.75% 5.48% - 8.91%
EBITDA Q/Q Growth		 -56.25% -33.71% 41.38% 0.61% 16.97% -10.88% -11.63% 14.47% -5.17% - 26.01%
EBIT Q/Q Growth		 -61.26% -43.26% 61.25% 1.55% 20.61% -13.92% -14.71% 19.83% -8.63% - 33.83%
NOPAT Q/Q Growth		 -56.29% -44.98% 65.42% 2.22% 24.01% -6.10% -24.30% 70.84% -35.02% - 24.32%
Net Income Q/Q Growth		 -62.35% -58.06% 97.44% 5.19% 30.86% -7.55% -30.61% 86.76% -38.58% - 35.29%
EPS Q/Q Growth		 -61.40% -56.25% 92.21% 6.76% 34.81% -7.04% -28.28% 90.85% -37.64% - 38.83%
Operating Cash Flow Q/Q Growth		 -32.67% -37.62% 55.56% 40.82% 3.62% -19.58% -13.04% 22.00% 5.74% - -50.78%
Free Cash Flow Firm Q/Q Growth		 -31.51% -31.04% -164.49% 184.52% 43.05% -7.49% -14.66% -2.15% -183.84% - 61.31%
Invested Capital Q/Q Growth		 0.32% 0.26% 0.08% -1.29% -0.51% 0.43% -0.05% 0.59% 5.13% - -0.13%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 12.08% 11.05% 11.53% 11.55% 11.99% 12.62% 11.13% 12.15% 12.17% - 13.06%
EBITDA Margin		 9.23% 6.68% 8.88% 9.08% 9.77% 9.36% 8.10% 9.84% 8.84% - 11.44%
Operating Margin		 7.55% 4.55% 7.09% 7.37% 8.10% 7.51% 6.45% 7.86% 6.86% - 9.39%
EBIT Margin		 7.44% 4.61% 6.98% 7.21% 8.00% 7.40% 6.18% 7.86% 6.81% - 9.34%
Profit (Net Income) Margin		 4.91% 2.25% 4.17% 4.46% 5.36% 5.33% 3.62% 7.18% 4.18% - 6.03%
Tax Burden Percent		 81.58% 81.25% 81.05% 81.00% 84.13% 91.59% 79.07% 117.59% 82.98% - 79.31%
Interest Burden Percent		 80.85% 60.00% 73.64% 76.34% 79.75% 78.68% 74.14% 77.70% 74.02% - 81.46%
Effective Tax Rate		 18.42% 18.75% 18.95% 19.00% 15.87% 8.41% 20.93% -17.59% 17.02% - 20.69%
Return on Invested Capital (ROIC)		 12.12% 7.09% 11.40% 11.60% 13.39% 13.66% 10.16% 18.37% 10.90% - 14.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.01% 5.91% 9.90% 10.24% 11.99% 12.30% 8.87% 16.70% 9.66% - 13.24%
Return on Net Nonoperating Assets (RNNOA)		 13.35% 7.23% 11.10% 11.94% 14.16% 15.25% 11.59% 23.19% 14.08% - 20.85%
Return on Equity (ROE)		 25.47% 14.32% 22.51% 23.54% 27.56% 28.91% 21.76% 41.56% 24.98% - 35.25%
Cash Return on Invested Capital (CROIC)		 21.68% 19.31% 7.86% 11.17% 12.49% 13.95% 13.80% 13.44% 6.90% - 12.33%
Operating Return on Assets (OROA)		 10.12% 6.32% 9.05% 9.63% 10.79% 10.48% 8.87% 11.22% 9.35% - 12.91%
Return on Assets (ROA)		 6.67% 3.08% 5.40% 5.95% 7.24% 7.55% 5.20% 10.25% 5.74% - 8.34%
Return on Common Equity (ROCE)		 25.40% 14.28% 22.51% 23.54% 27.56% 28.91% 21.76% 41.56% 24.98% - 35.25%
Return on Equity Simple (ROE_SIMPLE)		 28.06% 0.00% 25.92% 17.85% 18.80% 0.00% 23.46% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 117 64 106 109 135 126 96 163 106 114 142
NOPAT Margin		 6.16% 3.70% 5.75% 5.97% 6.81% 6.88% 5.10% 9.24% 5.69% - 7.45%
Net Nonoperating Expense Percent (NNEP)		 1.11% 1.18% 1.51% 1.36% 1.41% 1.36% 1.30% 1.67% 1.24% - 1.17%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.65% 2.76% - - 3.33% 2.53% 4.29% 2.66% 2.86% 3.63%
Cost of Revenue to Revenue		 87.92% 88.95% 88.47% 88.45% 88.01% 87.38% 88.87% 87.85% 87.83% - 86.94%
SG&A Expenses to Revenue		 4.59% 6.56% 4.60% 4.24% 4.20% 5.11% 4.74% 4.24% 5.41% - 4.35%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 4.54% 6.51% 4.44% 4.18% 3.90% 5.11% 4.69% 4.30% 5.31% - 3.67%
Earnings before Interest and Taxes (EBIT)		 141 80 129 131 158 136 116 139 127 133 178
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 175 116 164 165 193 172 152 174 165 173 218
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.18 3.72 3.82 3.88 4.44 3.36 3.74 3.42 2.85 - 2.93
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)		 0.76 0.89 0.92 0.86 0.97 0.71 0.75 0.70 0.59 - 0.57
Price to Earnings (P/E)		 11.34 13.91 14.72 21.73 23.64 14.62 15.95 13.01 11.62 - 10.28
Dividend Yield		 1.35% 1.16% 1.14% 1.20% 1.02% 1.37% 1.25% 1.34% 1.58% - 1.54%
Earnings Yield		 8.82% 7.19% 6.79% 4.60% 4.23% 6.84% 6.27% 7.69% 8.60% - 9.73%
Enterprise Value to Invested Capital (EV/IC)		 2.05 2.28 2.31 2.25 2.49 1.99 2.10 1.98 1.71 - 1.72
Enterprise Value to Revenue (EV/Rev)		 1.01 1.16 1.20 1.15 1.26 1.00 1.05 1.00 0.92 - 0.90
Enterprise Value to EBITDA (EV/EBITDA)		 8.42 9.80 10.23 13.58 14.54 10.74 11.53 10.76 10.19 - 8.96
Enterprise Value to EBIT (EV/EBIT)		 10.00 11.68 12.25 17.51 18.63 13.46 14.54 13.54 13.04 - 11.34
Enterprise Value to NOPAT (EV/NOPAT)		 12.74 15.16 15.88 21.29 22.42 15.66 16.88 14.26 13.67 - 12.44
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.23 21.82 21.23 21.05 20.99 15.09 15.86 15.49 14.50 - 10.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 9.18 11.54 30.39 20.07 19.79 14.20 15.13 14.74 25.49 - 14.07
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.24 1.18 1.18 1.33 1.34 1.41 1.52 1.51 1.64 - 1.75
Long-Term Debt to Equity		 1.20 1.13 1.13 1.21 1.20 1.21 1.25 1.22 1.64 - 1.73
Financial Leverage		 1.21 1.22 1.12 1.17 1.18 1.24 1.31 1.39 1.46 - 1.57
Leverage Ratio		 3.20 3.11 3.25 3.15 3.18 3.14 3.21 3.33 3.42 - 3.60
Compound Leverage Factor		 2.59 1.87 2.39 2.40 2.53 2.47 2.38 2.58 2.53 - 2.93
Debt to Total Capital		 55.32% 54.04% 54.22% 57.15% 57.25% 58.47% 60.25% 60.17% 62.19% - 63.60%
Short-Term Debt to Total Capital		 1.69% 1.98% 2.34% 5.20% 5.83% 8.24% 10.70% 11.76% 0.30% - 0.67%
Long-Term Debt to Total Capital		 53.63% 52.06% 51.87% 51.95% 51.42% 50.22% 49.55% 48.41% 61.89% - 62.93%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 44.68% 45.96% 45.78% 42.85% 42.75% 41.53% 39.75% 39.83% 37.81% - 36.40%
Debt to EBITDA		 2.46 2.38 2.44 3.50 3.38 3.20 3.34 3.32 3.75 - 3.41
Net Debt to EBITDA		 2.12 2.27 2.38 3.42 3.31 3.12 3.28 3.25 3.68 - 3.26
Long-Term Debt to EBITDA		 2.38 2.29 2.33 3.18 3.04 2.75 2.75 2.67 3.73 - 3.37
Debt to NOPAT		 3.72 3.68 3.78 5.48 5.22 4.66 4.90 4.40 5.03 - 4.73
Net Debt to NOPAT		 3.21 3.52 3.69 5.36 5.11 4.54 4.80 4.30 4.94 - 4.52
Long-Term Debt to NOPAT		 3.60 3.55 3.62 4.98 4.69 4.00 4.03 3.54 5.01 - 4.68
Altman Z-Score		 2.73 2.95 3.00 2.89 3.06 2.74 2.75 2.72 2.53 - 2.52
Noncontrolling Interest Sharing Ratio		 0.28% 0.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.13 0.98 0.95 0.85 0.87 0.83 0.78 0.83 1.20 - 1.16
Quick Ratio		 1.08 0.87 0.85 0.77 0.80 0.76 0.72 0.69 1.04 - 1.03
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 353 243 -157 133 190 175 150 146 -123 50 81
Operating Cash Flow to CapEx		 2,525.00% 572.73% 1,633.33% 2,300.00% 1,588.89% 766.67% 1,250.00% 1,742.86% 1,433.33% - 1,411.11%
Free Cash Flow to Firm to Interest Expense		 13.06 7.60 -4.61 4.28 5.93 6.05 4.99 4.72 -3.72 - 2.45
Operating Cash Flow to Interest Expense		 3.74 1.97 2.88 4.45 4.47 3.97 3.33 3.94 3.91 - 3.85
Operating Cash Flow Less CapEx to Interest Expense		 3.59 1.63 2.71 4.26 4.19 3.45 3.07 3.71 3.64 - 3.58
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.36 1.37 1.30 1.34 1.35 1.42 1.44 1.43 1.37 - 1.38
Accounts Receivable Turnover		 7.42 8.05 7.53 7.66 7.26 7.82 7.73 7.87 7.11 - 7.40
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover		 83.42 81.36 78.95 78.89 78.49 76.71 77.02 74.97 71.01 - 68.46
Accounts Payable Turnover		 8.17 11.04 8.80 8.85 8.40 11.00 10.06 10.98 9.65 - 9.80
Days Sales Outstanding (DSO)		 49.20 45.36 48.47 47.62 50.26 46.70 47.22 46.41 51.32 - 49.34
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)		 44.70 33.07 41.46 41.26 43.46 33.19 36.27 33.24 37.84 - 37.25
Cash Conversion Cycle (CCC)		 4.50 12.28 7.01 6.36 6.81 13.51 10.95 13.17 13.48 - 12.09
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,780 3,790 3,793 3,744 3,725 3,741 3,739 3,761 3,954 3,805 3,800
Invested Capital Turnover		 1.97 1.92 1.98 1.94 1.97 1.99 1.99 1.99 1.91 - 1.93
Increase / (Decrease) in Invested Capital		 -236 -179 263 -24 -55 -49 -54 17 229 64 61
Enterprise Value (EV)		 7,757 8,642 8,745 8,422 9,277 7,457 7,866 7,434 6,755 - 6,541
Market Capitalization		 5,805 6,637 6,711 6,303 7,164 5,293 5,632 5,190 4,313 - 4,164
Book Value per Share		 $34.53 $34.29 $34.06 $31.72 $32.55 $32.26 $31.53 $32.36 $32.85 $33.24 $32.77
Tangible Book Value per Share		 ($36.76) ($37.65) ($37.89) ($40.25) ($41.32) ($42.00) ($43.91) ($43.84) ($48.39) ($48.86) ($51.82)
Total Capital		 4,091 3,884 3,842 3,792 3,771 3,797 3,786 3,809 3,999 3,987 3,909
Total Debt		 2,263 2,099 2,083 2,167 2,159 2,220 2,281 2,292 2,487 2,487 2,486
Total Long-Term Debt		 2,194 2,022 1,993 1,970 1,939 1,907 1,876 1,844 2,475 2,468 2,460
Net Debt		 1,952 2,005 2,034 2,119 2,113 2,164 2,234 2,244 2,442 2,305 2,377
Capital Expenditures (CapEx)		 4.00 11 6.00 6.00 9.00 15 8.00 7.00 9.00 8.00 9.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -80 -44 -22 -40 -3.00 15 32 157 174 34 79
Debt-free Net Working Capital (DFNWC)		 231 50 27 8.00 43 71 79 205 219 216 188
Net Working Capital (NWC)		 162 -27 -63 -189 -177 -242 -326 -243 207 197 162
Net Nonoperating Expense (NNE)		 24 25 29 28 29 28 28 36 28 29 27
Net Nonoperating Obligations (NNO)		 1,952 2,005 2,034 2,119 2,113 2,164 2,234 2,244 2,442 2,305 2,377
Total Depreciation and Amortization (D&A)		 34 36 35 34 35 36 36 35 38 40 40
Debt-free, Cash-free Net Working Capital to Revenue		 -1.04% -0.59% -0.30% -0.55% -0.04% 0.20% 0.43% 2.10% 2.37% - 1.08%
Debt-free Net Working Capital to Revenue		 3.01% 0.67% 0.37% 0.11% 0.58% 0.95% 1.05% 2.75% 2.98% - 2.58%
Net Working Capital to Revenue		 2.11% -0.36% -0.87% -2.59% -2.40% -3.24% -4.34% -3.26% 2.82% - 2.22%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.79 $0.79 $1.49 $1.59 $2.15 $2.00 $1.43 $2.72 $1.70 $1.88 $2.63
Adjusted Weighted Average Basic Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Adjusted Diluted Earnings per Share		 $1.76 $0.77 $1.48 $1.58 $2.13 $1.98 $1.42 $2.71 $1.69 $1.88 $2.61
Adjusted Weighted Average Diluted Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M
Normalized Net Operating Profit after Tax (NOPAT)		 117 64 106 109 135 126 96 97 106 114 142
Normalized NOPAT Margin		 6.16% 3.70% 5.75% 5.97% 6.81% 6.88% 5.10% 5.50% 5.69% - 7.45%
Pre Tax Income Margin		 6.02% 2.76% 5.14% 5.50% 6.38% 5.82% 4.58% 6.11% 5.04% - 7.61%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 5.22 2.50 3.79 4.23 4.94 4.69 3.87 4.48 3.85 - 5.39
NOPAT to Interest Expense		 4.32 2.01 3.12 3.50 4.21 4.36 3.19 5.27 3.22 - 4.30
EBIT Less CapEx to Interest Expense		 5.07 2.16 3.62 4.03 4.66 4.17 3.60 4.26 3.58 - 5.12
NOPAT Less CapEx to Interest Expense		 4.17 1.66 2.95 3.31 3.93 3.84 2.92 5.05 2.95 - 4.03
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 15.79% 16.56% 17.11% 26.55% 25.08% 20.72% 20.96% 18.05% 19.14% - 16.79%
Augmented Payout Ratio		 84.41% 96.65% 104.17% 197.59% 194.72% 174.86% 190.09% 144.86% 148.52% - 138.02%

Financials Breakdown Chart

Key Financial Trends

Science Applications International (SAIC) has produced a mix of steady profitability and improving cash flow in recent quarters, with a solid operating base but rising leverage and capital allocations shaping risks and opportunities for investors. Here are the key takeaways drawn from SAIC's quarterly statements over the last four years.

  • Strong quarterly operating cash flow: Net cash from continuing operating activities was $258 million in Q4 2026, underscoring robust cash generation from core operations.
  • Estimated free cash flow remains healthy in Q4 2026: about $247 million (OCF of $258 million minus roughly $11 million in net investing cash outflows).
  • Dividend support for investors: SAIC has maintained a quarterly cash dividend per share of $0.37 in recent periods, providing a predictable income stream.
  • Financing flexibility via debt issuance: SAIC issued about $1.44 billion of debt in Q3 2026, reflecting access to capital markets to support liquidity and funding needs.
  • Revenue volatility: quarterly operating revenue tends to hover in the $1.75–$2.0 billion range across 2024–2026, with no clear, sustained uptrend in the near term.
  • Asset mix shows heavy goodwill and intangible assets: Goodwill around $2.85–$2.93 billion and intangible assets roughly $0.75–$1.0 billion, which could imply impairment risk if business conditions deteriorate.
  • Cash on hand remains modest: cash and equivalents typically sit around $45–$50 million in recent quarters, which may constrain liquidity if operating cash flow slows.
  • Rising leverage and interest burden: long-term debt sits in the ~$2.3–$2.5 billion range, contributing to increased interest costs (roughly $26–$34 million per quarter in the periods shown).
  • Share repurchases compress cash reserves: for example, about $98 million was spent on repurchasing common equity in Q4 2026.
  • Financing outflows pressuring cash balances: net cash from financing activities was negative in multiple quarters (e.g., around -$114 million in Q2 2026 and -$110 million in Q4 2026), signaling ongoing capital-allocation outlays beyond operating cash flow.
06/09/26 10:08 AM ETAI Generated. May Contain Errors.

Science Applications International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Science Applications International's fiscal year ends in January. Their fiscal year 2026 ended on January 30, 2026.

Science Applications International's net income appears to be on an upward trend, with a most recent value of $358 million in 2026, rising from $117 million in 2016. The previous period was $362 million in 2025. Check out Science Applications International's forecast to explore projected trends and price targets.

Science Applications International's total operating income in 2026 was $521 million, based on the following breakdown:
  • Total Gross Profit: $872 million
  • Total Operating Expenses: $351 million

Over the last 10 years, Science Applications International's total revenue changed from $4.32 billion in 2016 to $7.26 billion in 2026, a change of 68.3%.

Science Applications International's total liabilities were at $3.85 billion at the end of 2026, a 5.0% increase from 2025, and a 121.2% increase since 2016.

In the past 10 years, Science Applications International's cash and equivalents has ranged from $0.00 in 2018 to $237 million in 2019, and is currently $182 million as of their latest financial filing in 2026.

Over the last 10 years, Science Applications International's book value per share changed from 8.36 in 2016 to 33.24 in 2026, a change of 297.7%.


Related Companies

Financial statements for NASDAQ:SAIC last updated on 6/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel